Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/15/23 16:58 | 6/13/23 | NVTA | Health | Health | Medical Laboratories | Nussbaum Robert L | CA | O | Chief Me | 3 | S | -45 | 1.25 | 0 | -36 | 576 | D | |||||||||||||||
6/15/23 16:57 | 6/13/23 | NVTA | Health | Health | Medical Laboratories | Brida Thomas | CA | O | See Rema | 3 | S | -45 | 1.25 | 0 | -36 | 711 | D | |||||||||||||||
5/24/23 17:07 | 5/16/23 | NVTA | Health | Health | Medical Laboratories | Wen Yafei | CA | O | CFO | 3 | S | -142 | 1.59 | 0 | -90 | 700 | D | |||||||||||||||
5/18/23 16:20 | 3/13/23 | NVTA | Health | Health | Medical Laboratories | Knight Kenneth D. | CA | DO | CEO | 2 | S | -57 | 1.21 | 0 | -47 | 1,672 | D | |||||||||||||||
5/18/23 16:15 | 5/16/23 | NVTA | Health | Health | Medical Laboratories | Werner Robert F. | CA | O | Chief Ac | 1 | S | -26 | 1.20 | 0 | -22 | 355 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |